Trial Profile
A Comparison of Two Initial Dosing Formulas for Basal Insulin in Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 Feb 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 27 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jun 2011 New trial record